DIARRHOEA is the #11 most commonly reported adverse reaction for ENZALUTAMIDE, manufactured by Astellas Pharma US, Inc.. There are 2,783 FDA adverse event reports linking ENZALUTAMIDE to DIARRHOEA. This represents approximately 2.4% of all 117,902 adverse event reports for this drug.
Patients taking ENZALUTAMIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DIARRHOEA2,783 of 117,902 reports
DIARRHOEA is a less commonly reported adverse event for ENZALUTAMIDE, but still significant enough to appear in the safety profile.
Other Side Effects of ENZALUTAMIDE
In addition to diarrhoea, the following adverse reactions have been reported for ENZALUTAMIDE:
DIARRHOEA has been reported as an adverse event in 2,783 FDA reports for ENZALUTAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DIARRHOEA with ENZALUTAMIDE?
DIARRHOEA accounts for approximately 2.4% of all adverse event reports for ENZALUTAMIDE, making it a notable side effect.
What should I do if I experience DIARRHOEA while taking ENZALUTAMIDE?
If you experience diarrhoea while taking ENZALUTAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.